Jacobs Levy Equity Management
BIND

Jacobs Levy Equity Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Jacobs Levy Equity Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-89,900
Closed -$198K – 1322
2016
Q1 		$198K Buy
+89,900
New +$163K ﹤0.01% 975

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jacobs Levy Equity Management's BIND Position: Q2 2016 in Review

Jacobs Levy Equity Management sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 89,900 shares — an estimated $198K sold.

Jacobs Levy Equity Management first reported a position in BIND in Q1 2016 and held it in 1 quarter. The position peaked at $198K in Q1 2016. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

  • Jacobs Levy Equity Management reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 89,900 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $198K.
  • Jacobs Levy Equity Management first reported a position in BIND THERAPEUTICS INC in Q1 2016 and held it in 1 quarter.
  • Jacobs Levy Equity Management's BIND THERAPEUTICS INC position peaked at $198K in Q1 2016.
  • 21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.